home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login » Fund III Investor Login »

news

Tag: 2016

Dec14Bio-Techne and Astute Medical Form Strategic Partnership »


Minneapolis, MN and San Diego, CA - Dec. 14, 2016 – Bio-Techne Corporation (NASDAQ: TECH) today closed on a strategic equity investment in Astute Medical, Inc. (San Diego, CA), a diagnostic...

Read More »

Dec13Biodesix® Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy »


VeriStrat® Test Shown To Have Clinical Utility in Predicting Overall Survival of Afatinib-Treated Patients With Lung Cancer   December 13, 2016, Boulder, Colorado… Two studies demonstrating the clinical...

Read More »

Dec5Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in the United States »


Collaboration Marries Good Start’s Proprietary Technology with Roche Diagnostics’ Commercial Expertise for Broad Market Reach   CAMBRIDGE, Mass., December 5, 2016 /PRNewswire/ – Good Start Genetics, an information solutions...

Read More »

Dec4NeuroPace, Inc. Announces Results of 7 Years of Clinical Trial Follow-up Demonstrating 72 Percent Seizure Reduction with the RNS® System »


Study Presented at American Epilepsy Society Meeting Demonstrates Sustained Effectiveness in Adults with Drug-Resistant Partial Onset Epilepsy   Mountain View, Calif. & Houston --(BUSINESS WIRE)-- NeuroPace, Inc. today...

Read More »

Nov30Valeritas Elects Joe Mandato, Ph.D., Experienced Medical Device Executive and Investor, to Board of Directors »


BRIDGEWATER, N.J., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today the election of Joe Mandato, Ph.D., to the Company’s Board of Directors, effective...

Read More »

Nov29Tandem Diabetes Care to Draw Down $35 Million under Existing Term Loan Facility with CRG »


SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced that it has initiated the drawdown of $35 million under the company’s previously announced term loan...

Read More »

Nov21Omeros Announces Successful Outcome of OMIDRIA® Pediatric Cataract Trial »


Six-Month Extension of Patent Exclusivity and Label Expansion Expected   Seattle --(BUSINESS WIRE)-- Nov. 21, 2016 -- Omeros Corporation (NASDAQ: OMER) today announced the successful outcome of its...

Read More »

Nov17FDA Approves Intrarosa for Postmenopausal Women Experiencing Pain During Sex »


The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA),...

Read More »

Nov2Good Start Genetics Brings First Next-Generation Sequencing (NGS) Test to Amazon Enabling Broad Access to Carrier Screening for Couples Starting a Family »


Company Establishes Direct Relationship with Largest Online Retailer to Democratize Genetic Testing   Cambridge, MA (November 2, 2016)- Today, Good Start Genetics announced it has launched its VeriYouTM genetic test for...

Read More »

Oct28Omeros Announces $125 Million New Credit Facility »


Houston, Oct. 28, 2016 -- Omeros Corporation  (NASDAQ: OMER) today announced that it has entered into a senior credit facility with  CRG LP, a healthcare-focused investment firm, to retire the...

Read More »

Oct19CRG Appoints Adam Whitehead as Vice President of Investor Relations »


Houston, Oct. 19, 2016 -- CRG, a global healthcare-focused investment firm supporting innovative healthcare companies, announced today the appointment of Adam Whitehead as Vice President of Investor Relations in the...

Read More »

Oct18CRG Provides Investment Update, Committing $458 Million to New Healthcare Investments in 2016 »


Houston, Oct. 18, 2016 -- CRG, a global healthcare-focused investment firm supporting innovative healthcare companies, today announced cumulative financing commitments of $458 million across eight public and private, commercial-stage healthcare companies since the...

Read More »

Oct14Cardiome Announces Initiation of Commercial Operations in Canada, EH »


Vancouver, Canada, October 14, 2016 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has initiated commercial sales operations in Canada. The Canadian sales force will immediately begin detailing AGGRASTAT...

Read More »

Oct4GenomeDx and Bostwick Laboratories Announce Marketing Agreement for Decipher Prostate Cancer Classifier Test »


San Diego, CA, Uniondale, NY, October 4, 2016 – GenomeDx Biosciences and Bostwick Laboratories, Inc. today announced that Bostwick has entered into a marketing partnership agreement with GenomeDx, provider of the...

Read More »

Sep22Industry Veteran Katherine D. Crothall, PhD to Join Valeritas Board of Directors »


BRIDGEWATER, N.J., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today the election of Katherine D. Crothall, PhD, to the Company’s Board of Directors, effective...

Read More »

Sep19ViewRay Receives CE Mark Approval for its MRIdian Linac System »


-- 510(k) Application Submitted to the FDA --   CLEVELAND, September 19, 2016 — ViewRay, Inc. (Nasdaq: VRAY)announced today that the company has received CE Mark approval for its next generation...

Read More »

Sep15Silk Road Medical Announces New Medicare Coverage Option for TransCarotid Artery Revascularization (TCAR) Procedures »


--Medicare to Cover Procedures within the TCAR Surveillance Project Sponsored by the Society for Vascular Surger--   SUNNYVALE, Calif., Sept. 15, 2016 /PRNewswire/ — Silk Road Medical, Inc., a company dedicated to...

Read More »

Sep8Specialists On Call, Inc. Raises $50 Million in Capital »


Financing to Accelerate Growth of the Business Through Investments and Acquisitions    Reston, VA – September 8, 2016 – Specialists On Call, Inc. (“SOC”), the nation’s leading...

Read More »

Aug19ViewRay Announces $13.75 Million Private Placement »


--Company preparing for introduction of MRIdian Linear Accelerator Technology--   CLEVELAND, August 19, 2016 — ViewRay, Inc. (Nasdaq: VRAY)announced today that it has entered into a definitive agreement in connection with...

Read More »

Aug16Avinger, Inc. Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares »


Redwood City, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (the “Company”), a leading developer of innovative treatments for peripheral artery disease (&ldquo...

Read More »

Aug9Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency »


Vancouver, Canada, August 9, 2016 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that XYDALBA™ (dalbavancin) has been approved by the European Medicines Agency (EMA) for administration as a single, 30...

Read More »

Jul26Cardiome Announces Pricing of Public Offering of 10,000,000 Common Shares »


Vancouver, Canada, July 26, 2016 – Cardiome Pharma Corp. (“Cardiome” or the “Company”) (NASDAQ: CRME / TSX: COM) announced today the pricing of its previously announced underwritten public offering ...

Read More »

Jul13Valeritas Appoints Brian K. Roberts to its Board of Directors »


BRIDGEWATER, N.J. , July 13, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today the appointment of Brian K. Roberts to the Company’s Board of Directors. Mr. Roberts...

Read More »

Jun29Iroko Pharmaceuticals Secures Debt Financing From CRG »


PHILADELPHIA - June 29, 2016 - PRNewswire -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has entered into...

Read More »

Jun15Avinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG »


--- Additional funding to support commercialization of Pantheris™ ---   REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral...

Read More »

Jun14Cardiome Announces Term Loan Agreement with CRG-Managed Funds »


VANCOUVER, Canada, June 14, 2016 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today announced that it has entered into a term loan agreement (the "Agreement") with...

Read More »

Jun13Nevro Announces Full Exercise of Over-Allotment Option and Closing of Public Offering of $172.5 Million Convertible Senior Notes »


Redwood City, Calif., June 13, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...

Read More »

May26Cigna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay »


Seattle, May 26, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of molecular diagnostic testing products and life science tools for translational research, today announced...

Read More »

May25CRG Promotes David Carter to Managing Director »


Houston, TX - May 25, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the global healthcare market, announced today that David Carter has been promoted to Managing...

Read More »

May19Two-Year Study Results Show the Pulsante® Microstimulator Provides Sustained, Longterm Relief for Cluster Headache Patients »


New hope for cluster headache sufferers   Redwood City, USA, May 19th, 2016 – A peer-reviewed paper* in the International Headache Society journal Cephalagia reported that cluster headache patients treated with...

Read More »

May12FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX Device »


EsophyX® Z Fastener Delivery System requires fewer steps for Transoral Incisionless Fundoplication (TIF) procedures   REDMOND, Washington—EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for...

Read More »

May9Aetna Issues Positive Coverage Decision for NanoString's Prosigna® Breast Cancer Assay »


SEATTLE, May 09, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of molecular diagnostic testing products and life science tools for translational research, today announced...

Read More »

May4TearLab Announces $17.3 Million Registered Public Offering »


SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) announced today the pricing of a public offering of...

Read More »

May4Valeritas Completes Alternative Public Offering and Raises Gross Proceeds of $25.2 Million »


--Funding Will Support Continued Commercialization of the V-Go® Disposable Insulin Delivery Device and Advance Next Generation Products--   BRIDGEWATER, New Jersey, May 4, 2016 – Valeritas Holdings, Inc. (OTCQB: VLRX) announced...

Read More »

Apr25Peter J. Devlin Joins Valeritas Board of Directors as Independent Director »


BRIDGEWATER, New Jersey, April 25, 2016 – Valeritas, Inc. announced today that Peter J. Devlin has been elected to the company's Board of Directors as an independent director. Peter has more...

Read More »

Apr25Exagen Points the Way for Patients with Difficult-to-Diagnose Lupus »


San Diego, CA – Exagen Diagnostics, a rheumatology specialty laboratory with offices in Vista, CA, and Albuquerque, NM, is focused on helping patients and their doctors get speedier and more...

Read More »

Apr19Rodney D. Altman, MD Joins Valeritas Board of Directors »


-- Valeritas Expands Its Board of Directors --   BRIDGEWATER, New Jersey, April 19, 2016 – Valeritas, Inc. announced today that Rodney D. Altman, MD has been elected to the company's...

Read More »

Apr12ViewRay® Appoints Dr. Henry A. McKinnell, Jr. to its Board of Directors »


--Former Pfizer Chairman and CEO Brings Extensive Experience in Life Sciences and Public Companies--   CLEVELAND, April 12, 2016 — ViewRay, Inc. (Nasdaq: VRAY) announced today the appointment of Henry A. McKinnell,...

Read More »

Apr4200 Million Americans Now Have Insurance Coverage for Biodesix’ VeriStrat Test »


VeriStrat®, Biodesix’ proteomic blood test for patients with advanced NSCLC, has received multiple positive coverage decisions in 2016. As a result, 200 million Americans now have insurance coverage for VeriStrat....

Read More »

Mar8GenomeDx Biosciences Launches Decipher Biopsy Test »


New Predictor of Prostate Cancer Disease Progression Now Available for Newly Diagnosed Patients   San Diego – March 8, 2016 – GenomeDx Biosciences today announced the launch of Decipher Biopsy, a...

Read More »

Feb25Valeritas Announces Leadership and Board of Directors Changes »


-- John Timberlake Named as Interim CEO --   BRIDGEWATER, New Jersey, February 25, 2016 – Valeritas, Inc. announced today changes to its executive team this week. John Timberlake has been named...

Read More »

Feb4GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy »


-- Company’s Proprietary Genomic Classifier Demonstrates Unprecedented Accuracy in Diagnostic Biopsies Study Published in Urology --   San Diego, Feb 4, 2016 -- GenomeDx Biosciences today announced publication of results...

Read More »

Feb1TearLab Announces Proposed Public Offering of Common Stock »


San Diego, Feb. 01, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ: TEAR) (TSX: TLB) (“TearLab” or “the Company”) announced today its intention to offer, subject to market and...

Read More »

Feb1CRG Fund II Closes $167 Million Term Loan Securitization »


-- Financing Receives A- Rating by the Kroll Bond Rating Agency --   NEW YORK, NY, February 1, 2016 – CRG, a healthcare-focused investment firm delivering pioneering growth capital solutions to the...

Read More »

Jan18Autonomic Technologies Secures Financing from CRG »


January 18, 2016 – Autonomic Technologies, Inc. (“ATI”), a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache, secured expansion financing...

Read More »

Jan12Tandem Diabetes Care Amends Term Loan Facility with CRG »


Increased Borrowing Capacity to Provide Flexibility for Anticipated Growth   San Diego --(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) today announced the amendment of its term...

Read More »

Jan7NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to Develop Novel Companion Diagnostic Test »


-- NanoString Eligible to Receive up to $22 Million for Technology Access, Near-Term Milestones and Development Funding --    SAN FRANCISCO, CA and SEATTLE, WA-- (Marketwired - Jan 7, 2016) - Medivation,...

Read More »

Jan7GenomeDx’s Decipher® Test Validated to Predict Metastasis from Prostate Cancer Biopsies »


-- Data to Be Presented at 2016 Genitourinary Cancers Symposium --   San Diego, Jan. 7, 2016 -- GenomeDx Biosciences today announced the first validation data supporting use of the Decipher® Prostate...

Read More »

Jan6Benvenue Medical Secures $60 Million Financing »


-- Spine Company to Accelerate Commercialization of Luna® 3D Interbody Fusion System and Kiva® VCF Treatment System --   SANTA CLARA, Calif. -- January 6, 2016   Benvenue Medical, Inc.,...

Read More »